Literature DB >> 30898690

Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.

Bruno Sposato1, Marco Scalese2, Manlio Milanese3, Simonetta Masieri4, Carlo Cavaliere4, Manuela Latorre5, Nicola Scichilone6, Alberto Ricci7, Alberto Cresti8, Pierachille Santus9, Carmela Olivieri10, Antonio Perrella10, Paola Rogliani11, Pierluigi Paggiaro5.   

Abstract

Entities:  

Year:  2019        PMID: 30898690     DOI: 10.1016/j.jaip.2019.03.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.

Authors:  Manuela Latorre; Elena Bacci; Veronica Seccia; Maria Laura Bartoli; Cristina Cardini; Silvana Cianchetti; Ludovica Cristofani; Antonella Di Franco; Mario Miccoli; Ilaria Puxeddu; Alessandro Celi; Pierluigi Paggiaro
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 2.  The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians.

Authors:  Nicola Scichilone; Peter John Barnes; Salvatore Battaglia; Alida Benfante; Robert Brown; Giorgio Walter Canonica; Gaetano Caramori; Mario Cazzola; Stefano Centanni; Antonella Cianferoni; Angelo Corsico; Giuseppe De Carlo; Fabiano Di Marco; Mina Gaga; Catherine Hawrylowicz; Enrico Heffler; Maria Gabriella Matera; Andrea Matucci; Pierluigi Paggiaro; Alberto Papi; Todor Popov; Paola Rogliani; Pierachille Santus; Paolo Solidoro; Alkis Togias; Louis-Philippe Boulet
Journal:  J Clin Med       Date:  2020-07-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.